Cannabinoid Therapy Shows Promise for Autoimmune Diseases, Biotech Firm Files Patent
Read full article
Mark Peterson
Reading the market’s next move: deconstructing the deals and disruptions that move the world.
MP
Editor
Mark Peterson
About This Column
Mark Peterson is an analyst of the maneuvers that redefine global industry. Formerly the voice behind Strategic Transactions & Market Disruptors, Mark has expanded his lens to investigate how high-stakes deals serve as the ultimate signals of future market dominance. He specializes in deconstructing the "why" behind corporate maneuvers - dissecting M&A activity, IPOs, and strategic realignments to uncover what they telegraph about the next decade of growth and competition. His column is a destination for those who want to understand the intersection of capital, technology, and the evolving corporate landscape.
Displaying items 741-741 of 741 in total
UCID: 2